BillionToOne, Inc.
Status: Publicly traded
Direct answer
BillionToOne, Inc. is publicly traded on NASDAQ under the ticker BLLN.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY...
Can you invest in BillionToOne, Inc.?
Yes. BillionToOne, Inc. trades publicly on NASDAQ as BLLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BillionToOne, Inc.
Detailed equity research is provided by MarketSnap.